Pathstone Family Office’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $388K | Buy |
+3,204
| New | +$388K | ﹤0.01% | 1162 |
|
|
2021
Q1 | – | Sell |
-23
| Closed | -$4K | – | 1246 |
|
|
2020
Q4 | $4K | Sell |
23
-181
| -89% | -$31.5K | ﹤0.01% | 967 |
|
|
2020
Q3 | $29K | Buy |
204
+149
| +271% | +$21.2K | ﹤0.01% | 432 |
|
|
2020
Q2 | $9K | Sell |
55
-20
| -27% | -$3.27K | ﹤0.01% | 535 |
|
|
2020
Q1 | $7K | Buy |
+75
| New | +$7K | ﹤0.01% | 588 |
|
|
2019
Q4 | – | Sell |
-51
| Closed | -$4K | – | 600 |
|
|
2019
Q3 | $4K | Buy |
+51
| New | +$4K | ﹤0.01% | 546 |
|
|
2019
Q2 | – | Sell |
-45
| Closed | -$5K | – | 868 |
|
|
2019
Q1 | $5K | Hold |
45
| – | – | ﹤0.01% | 606 |
|
|
2018
Q4 | $5K | Buy |
+45
| New | +$5K | ﹤0.01% | 379 |
|